 - Women of childbearing age must have a negative pregnancy test and must use adequate contraception during the treatment and follow-up phase of the study three pregnancy tests will be required prior to and during the study: 1 during the screening phase, 2 about one week prior to leukapheresis, and 3 about one week prior to re-infusion of autologous cells 